2-(4-Isopropoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

((2S,4R)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 1g

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging

(5-(4-Chlorophenyl)-3-isoxazolyl)methanol, 95.0%, 1g

1-Methylisatin>98.0%(GC)5g

4'-Fluoro-3'-nitroacetophenone>98.0%(GC)25g

(4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate, 98.0%, 25g

(1r)-1-(3-Bromo-4-methoxyphenyl)ethan-1-ol, 98%, 500mg

Octanedioic acid, 95.0%, 10g

Methyl 2-chloro-4-(trifluoromethyl)benzoate, 98%, 5g

4-cyclohexyl-3-{[(3-methoxyphenyl)amino]methyl}-4,5-dihydro-1H-1,2,4-triazole-5-thione, 100mg

4'-Methoxy-biphenyl-4-sulfonyl chloride, 90.0%, 5g

(R)-METHYL 5-OXOPYRROLIDINE-3-CARBOXYLATE, 95.0%, 250mg